Go Deep
Impact BioMedical Inc.
Impact BioMedical Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 26,709 | 0.3 | 2.51 | 0.10 | 299.15 |
| Oct 2026 | 27,127 | 0.3 | 2.13 | 0.10 | 253.84 |
| Oct 2026 | 26,795 | 0.3 | 2.43 | 0.10 | 290.14 |
| Oct 2026 | 26,614 | 0.3 | 2.59 | 0.10 | 309.81 |
| Oct 2026 | 25,957 | 0.4 | 3.19 | 0.10 | 380.22 |
| Oct 2026 | 26,149 | 0.3 | 3.02 | 0.10 | 358.69 |
Impact BioMedical Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 3,000.0 | 7,000.0 | 7,000.0 | 18,000.0 |
| Net Profit | -699,000.0 | -2,287,000.0 | 5,245,000.0 | -1,470,000.0 |
| EPS | -0.0 | -0.0 | — | -0.1 |
Impact BioMedical Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 32,000.0 | 0.0 | 0.0 | 50,000.0 | — |
| Net Profit | -11,838,000.0 | -24,708,000.0 | -4,336,000.0 | -7,051,000.0 | — |
| EPS | -0.4 | -2.3 | -0.1 | -0.6 | — |
Impact BioMedical Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 17,405,000.0 | 20,290,000.0 | 44,633,000.0 | 46,497,000.0 | — |
| Total Liabilities | 1,850,000.0 | 13,053,000.0 | 16,371,000.0 | 13,828,000.0 | — |
| Total Equity | 12,609,000.0 | 4,259,000.0 | 25,222,000.0 | 29,558,000.0 | — |
Owes vs Owns
Impact BioMedical Inc. owed $0.16 for every $1 it owned in Jun 2026, down from $0.30 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.16× | 0.11× | 0.64× | 0.37× | 0.30× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Impact BioMedical Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Receivables 1.2%Intangible assets 97.6%Other assets 0.8%
How it's funded — Dec 2025
Payables 2.0%Other liabilities 8.6%Shareholders' equity 89.4%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 0.0 | 2.0 | 0.0 | 0.0 |
| Receivables | 0.2 | 0.2 | 0.3 | 0.0 |
| Inventory | 0.1 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.0 | 0.0 | 0.3 | 0.3 |
| Intangible assets | 17.0 | 17.8 | 44.0 | 45.1 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.8 |
| Other assets | 0.1 | 0.3 | 0.0 | 0.3 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 8.9 | 12.1 | 10.0 |
| Long-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Payables | 0.3 | 0.3 | 0.8 | 0.5 |
| Other liabilities | 1.5 | 3.9 | 3.5 | 3.3 |
| Shareholders' equity | 15.6 | 7.2 | 28.3 | 32.7 |
| Net tangible assets | -4.4 | -13.5 | -18.8 | -15.6 |
Impact BioMedical Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -1,890,000.0 | -2,854,000.0 | -2,851,000.0 | -2,242,000.0 | — |
| Investing Activities | 3,000.0 | 2,000.0 | -15,000.0 | -349,000.0 | — |
| Financing Activities | -109,000.0 | 4,850,000.0 | 2,865,000.0 | 2,547,000.0 | — |